Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia
Oussama ElMokh(University of Bern), Michel A. Duchosal(Scripps Health), Aimable Nahimana(University of Lausanne), Saki Matsumoto(University of Lausanne), Axel Bellotti(University Hospital of Lausanne), Paulina Biniecka(University of Lausanne), Julijana Ivanišević(University of Lausanne), Héctor Gallart‐Ayala(University of Lausanne), Francesco Piacente(University of Genoa), Alessio Nencioni(Ospedale Policlinico San Martino), Karin Schaeuble(University of Basel), Ivan Stamenkovic(University Hospital of Lausanne)
Cited by 16
Related Papers
Extracellular matrix remodelling: the role of matrix metalloproteinases
|The Journal of Pathology|2003|1.1k
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
|Cancer Research|2005|360
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.
|The Journal of Experimental Medicine|1994|341